Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays.
early secreted antigenic target 6
heparin-binding hemagglutinin
interferon gamma release assay
latent tuberculosis infection
whole blood
Journal
Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564
Informations de publication
Date de publication:
18 05 2022
18 05 2022
Historique:
pubmed:
19
4
2022
medline:
21
5
2022
entrez:
18
4
2022
Statut:
ppublish
Résumé
Optimal detection of latent tuberculosis (TB) infection (LTBI) remains a challenge, although it is essential to reach the goal of TB elimination. Our objective was to develop and clinically evaluate a user-friendly, 24-h, whole-blood (WB) interferon gamma (IFN-γ) release assay (IGRA) improving the detection of LTBI, compared to available tests. One milliliter of blood was divided into four aliquots and
Identifiants
pubmed: 35430897
doi: 10.1128/jcm.02443-21
pmc: PMC9116186
doi:
Substances chimiques
Antigens, Bacterial
0
Lectins
0
heparin-binding hemagglutinin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0244321Subventions
Organisme : Tuberculosis Vaccine Initiative
ID : NORAD
Organisme : INNOV-IRIS Brussels
Organisme : European Commission (EC)
ID : HEALTH-2009-2.3.2-2
Organisme : Fonds De La Recherche Scientifique - FNRS (FNRS)
ID : PDR T.0147.13
Références
J Immunol. 2018 Nov 1;201(9):2541-2548
pubmed: 30348659
J Clin Microbiol. 2020 Aug 24;58(9):
pubmed: 32493779
Tuberculosis (Edinb). 2017 Sep;106:62-72
pubmed: 28802407
Int J Infect Dis. 2020 Feb;91:177-181
pubmed: 31877486
Nat Med. 2004 Sep;10(9):935-41
pubmed: 15300244
Adv Med Sci. 2019 Sep;64(2):437-443
pubmed: 31586819
PLoS One. 2007 Oct 03;2(10):e926
pubmed: 17912342
PLoS One. 2011 Mar 29;6(3):e18315
pubmed: 21479248
Eur Respir J. 2009 May;33(5):956-73
pubmed: 19407047
Lancet Infect Dis. 2017 Oct;17(10):e327-e333
pubmed: 28495525
Tuberculosis (Edinb). 2018 Jan;108:136-142
pubmed: 29523314
Clin Vaccine Immunol. 2007 Jul;14(7):880-5
pubmed: 17507543
PLoS One. 2012;7(8):e43285
pubmed: 22912846
Infect Immun. 2006 May;74(5):3006-11
pubmed: 16622240
Am J Respir Crit Care Med. 2017 Sep 1;196(5):638-648
pubmed: 28737960
Nat Rev Immunol. 2018 Sep;18(9):575-589
pubmed: 29895826
Clin Vaccine Immunol. 2014 Mar;21(3):321-8
pubmed: 24391135
Lancet Infect Dis. 2018 Oct;18(10):1077-1087
pubmed: 30174209
BMC Nephrol. 2020 Jun 4;21(1):214
pubmed: 32498706
J Infect. 2018 Dec;77(6):526-533
pubmed: 30267797
PLoS One. 2021 Jul 16;16(7):e0254571
pubmed: 34270559
Expert Rev Vaccines. 2015;14(12):1573-85
pubmed: 26517361
Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1415-1423
pubmed: 28429162
J Clin Invest. 2021 Feb 1;131(3):
pubmed: 33529162
Curr Med Chem. 2019;26(11):2051-2060
pubmed: 30378481
J Microbiol. 2016 Aug;54(8):565-72
pubmed: 27480637
Am J Respir Crit Care Med. 2007 Aug 15;176(4):409-16
pubmed: 17541018
PLoS One. 2017 Nov 28;12(11):e0188631
pubmed: 29182688
BMC Infect Dis. 2009 Nov 21;9:182
pubmed: 19930588